Building a Prescription Assistance Process That Prevents Gaps in Medication Access
A prescription can be clinically appropriate and still fail as a treatment plan if the patient cannot afford to fill it.
Medical practices encounter this problem in different ways. A patient may tell the provider that a medication is too expensive. A pharmacy may send a message about coverage. Staff may discover that a prescribed drug requires prior authorization. Another patient may quietly stop taking a medication and mention the cost only months later.
This pattern lines up with CDC data showing cost-related medication nonadherence affects roughly one in twelve working-age adults who take prescription drugs.
These situations are often handled individually, depending on which employee happens to receive the question. That makes medication affordability dependent on staff memory rather than a reliable process.
Practices do not need to become experts on every prescription assistance program. They do need a prescription assistance workflow for recognizing medication-access barriers and determining what type of problem exists. The workflow should direct patients toward appropriate resources and make sure unresolved issues do not disappear between the prescribing decision and the pharmacy.
Key Takeaways
- Identify whether the medication-access barrier involves coverage, authorization, cost sharing, or broader affordability before searching for assistance.
- Give medication-cost concerns a defined workflow entry point, owner, next action, and method for identifying unresolved work.
- Keep payer coverage workflows separate from prescription assistance while involving clinical staff whenever affordability could affect treatment decisions.
- Verify current assistance-program eligibility requirements instead of assuming that a patient qualifies.
- Track medication-access work through an appropriate outcome or handoff rather than treating application submission as resolution.
- Review recurring medication, payer, and workflow barriers so individual access problems can inform broader operational improvements.
Table of Contents
Identify the Medication-Access Problem Before Looking for Assistance
“It’s too expensive” can describe several different problems.
The medication may not be on the patient’s formulary. It may require prior authorization or step therapy. The patient may have a high cost-sharing obligation under the pharmacy benefit. A preferred or in-network pharmacy may affect what the patient pays.
A manufacturer assistance program may exist. In other situations, the patient may be considering paying cash rather than processing the prescription through insurance.
Those situations require different responses. Treating them as the same problem can send staff down the wrong administrative pathway and delay access to the medication.
Before staff start searching for discount programs, the practice should determine whether the barrier is primarily coverage, authorization, cost sharing, or general affordability.
| Medication Barrier | What the Practice Should Clarify | Possible Next Step |
|---|---|---|
| Drug not covered | Formulary status and covered alternatives | Clinical review of appropriate covered alternatives |
| Prior authorization | Payer requirements and documentation | Authorization workflow |
| Step therapy | Required prerequisite treatment and applicable exceptions | Clinical and payer review |
| High patient cost | Benefit information and available options | Assistance-resource review |
| No prescription coverage | Patient’s payment options | Cash-price or assistance resources |
| Ongoing affordability problem | Potential eligibility for longer-term assistance | Appropriate government, manufacturer, charitable, or other assistance resource |
This distinction prevents staff from treating every pharmacy problem as a search for a coupon. It also helps the practice route the problem to the person who can actually move it forward.
Operational Snapshot
The first operational decision is routing, not resource research. Classifying the barrier before work begins reduces wasted staff effort and helps prevent an affordability inquiry from masking a coverage restriction that requires payer action or a treatment question that requires clinical review.
Separate Coverage Problems From Assistance Programs
Prescription assistance should not replace routine pharmacy-benefit management.
If the payer requires prior authorization, staff should follow the applicable authorization process. If the drug is non-formulary, the provider may need to determine whether a clinically appropriate covered alternative exists. If the problem involves quantity limits or step therapy, those requirements should be evaluated through the applicable payer workflow.
Assistance programs become relevant when affordability remains a barrier or when the patient’s circumstances make an assistance resource appropriate.
Keeping those pathways separate is operationally important. Otherwise, employees can spend significant time searching for discounts while an unresolved formulary or authorization requirement continues to prevent the prescription from being filled.
The clinical team also needs to remain involved whenever affordability could require a change in treatment. Administrative staff can help identify resources and clarify administrative requirements, but they should not independently substitute medications, alter dosing, or determine clinical equivalence.
Build a Prescription Assistance Workflow With Clear Ownership
Create a Clear Trigger for Prescription Assistance
Medication affordability should have an identifiable entry point into the workflow.
Patients may disclose cost concerns during rooming, medication reconciliation, checkout, telephone conversations, or portal messages. Staff should know what to do when that happens.
The process does not need to begin with an extensive financial assessment. A simple question about whether cost is preventing the patient from obtaining or taking a medication can be enough to identify the need for follow-up.
What matters is where the concern goes next.
If the practice has no routing process, the information may remain buried in a visit note or telephone message. The provider may assume someone is helping the patient. Administrative staff may assume the clinical team is handling it. The patient can remain without the medication.
A cost concern should therefore create a task with an identifiable owner, a next action, and a way to determine whether the problem remains unresolved.
Operational Snapshot
A medication-cost disclosure becomes operationally actionable only when it creates accountable work. Practices can treat ownership, next action, and unresolved status as basic control fields, making it possible to distinguish a documented concern from a medication-access problem that is actually being managed.
Define Staff Responsibilities
Medication assistance can consume substantial administrative time if nobody knows where one employee’s responsibility ends and another’s begins.
A defined workflow might assign responsibilities such as:
- clinical staff identifying affordability barriers during medication reconciliation or patient communication
- designated staff reviewing available assistance resources and application requirements
- providers completing clinical or prescribing portions of applications when required
- authorization staff managing payer coverage restrictions separately
- staff documenting pending applications and required follow-up
- a designated owner monitoring unresolved medication-access tasks
Not every practice needs a dedicated medication-assistance employee. Smaller practices may assign the responsibility to an existing clinical or administrative role. Larger organizations may centralize the work.
The important point is that patients should not receive a different process depending on which employee happens to answer the phone. Defined ownership also gives leadership a way to determine where unresolved medication-access problems are accumulating instead of discovering them one patient at a time.
Use Prescription Assistance Resources Carefully
Understand That Assistance Options Have Different Rules
Prescription assistance is not one category.
Patients may encounter government assistance, manufacturer patient assistance programs, manufacturer savings offers, pharmacy cash-pricing programs, charitable resources, state programs, and other discount arrangements.
Eligibility varies, and the rules that apply to one type of assistance should not be assumed to apply to another.
Medicare beneficiaries with limited income and resources, for example, may qualify for Extra Help with Part D costs. Medicaid prescription coverage, cost sharing, and related requirements depend on the applicable state program and the patient’s coverage.
Manufacturer programs establish their own eligibility criteria and documentation requirements. They also establish their own renewal periods and distribution processes.
Manufacturer copayment coupons and similar savings offers require additional caution. Some programs exclude patients whose prescriptions are paid for in whole or in part by Medicare, Medicaid, or other federal healthcare programs. Staff should review the current terms of the specific program rather than assuming that a patient is eligible based only on the medication prescribed.
The practice should therefore avoid telling patients that a particular program will work until current eligibility requirements have been reviewed and the program has made any required eligibility determination.
Compliance Alert
Treat assistance eligibility as something to verify, not infer. Program terms can differ by coverage type and change over time, so staff scripts and resource guides should direct employees to current program criteria rather than encouraging definitive eligibility statements before the applicable requirements are checked.
A resource list is useful. A guarantee is not.
Be Careful When Comparing Insurance With Cash Pricing
Cash-price and prescription-discount tools can sometimes provide patients with another way to evaluate pharmacy costs.
However, staff should understand that paying cash or using a discount arrangement outside the patient’s prescription drug plan may be treated differently from filling the prescription through insurance.
For a patient with Medicare Part D, for example, a prescription purchased outside the Part D benefit generally should not be assumed to count toward the patient’s Part D deductible or true out-of-pocket (TrOOP) calculation. The treatment of a particular payment depends on Part D rules and the circumstances of the transaction.
That distinction can matter over the course of the benefit year. A lower cash price for one prescription does not automatically mean the transaction will have the same effect on the patient’s insurance benefits as a prescription processed through the drug plan.
Operational Snapshot
The lowest price at the pharmacy counter and the lowest overall benefit-year cost are not necessarily the same calculation. Staff discussing cash or discount options should therefore frame price as one decision input while directing patients to verify how an alternative payment method interacts with their coverage.
Practice staff do not need to make financial decisions for patients. They should be able to explain that insurance and cash-discount transactions may be treated differently and encourage patients to confirm how an option affects their coverage before deciding.
Maintain Resources Without Building an Unmanageable Directory
A quick-reference resource can save staff time, but it needs to be designed for maintenance. A long spreadsheet containing pharmacy prices, coupon amounts, program promises, and application details can become inaccurate quickly. Manufacturer requirements, commercial discount programs, and pharmacy pricing can change.
Instead, the practice can maintain a smaller set of reliable starting points. These can include government assistance resources and commonly used manufacturer assistance portals. They can also include prescription-cost comparison resources the practice has chosen to reference and internal instructions for who handles applications.
The resource should direct staff to current information rather than attempting to reproduce every program’s requirements internally. That reduces the risk that an old internal document becomes the source of an incorrect eligibility statement or outdated program instruction.
Technical Deep Dive
Design the internal resource as a routing layer rather than a duplicate program database. Linking staff to authoritative, current sources minimizes maintenance burden and reduces the chance that static internal fields such as prices, eligibility thresholds, or application instructions silently become obsolete.
Someone should also be responsible for reviewing the resource periodically and removing or updating information that is no longer current.
Track Medication-Access Problems Through Resolution
Document Assistance as an Open Workflow
Documentation becomes especially important when prescription assistance requires forms, income information, provider signatures, or repeated communication with an outside program.
The record should allow another staff member to understand what has already happened, what remains outstanding, and who is responsible for the next action.
Useful documentation may include the medication involved, the affordability barrier identified, and the resource or program being explored. It may also include application status, outstanding requirements, and the next follow-up step.
The practice should avoid creating unnecessary duplicate repositories of sensitive patient information merely for tracking purposes. When documentation belongs in the EHR or another approved system, staff should use the established system rather than creating informal spreadsheets containing patient details.
Technical Deep Dive
Continuity depends on shared workflow visibility, not on maintaining a separate tracking file. The approved system should make status, ownership, outstanding requirements, and next action visible enough for authorized staff to resume the work without creating a parallel repository of patient information.
The operational goal is continuity. If the employee who started an application is absent, another authorized staff member should be able to determine what has already been completed and whether the patient is still waiting for medication access.
Do Not Treat an Application as Resolution
Submitting paperwork is not the same as solving the patient’s medication problem.
Applications can be incomplete. Additional documentation may be requested. Eligibility may be denied. Medication delivery may be delayed. Assistance may expire and require renewal.
That means the workflow needs a closing point.
A prescription-access issue should remain open until the practice knows the appropriate next step has occurred. The patient may have received the information or assistance the practice is responsible for providing, or responsibility may have clearly transitioned to another appropriate party.
Operational Snapshot
Workflow closure should be tied to an outcome or explicit handoff rather than completion of an administrative step. This distinction gives leadership a more meaningful definition of backlog and helps surface cases where paperwork is finished but medication access remains unresolved.
This is particularly important when the medication is clinically significant, and an interruption could affect the treatment plan. If the administrative pathway does not resolve the access problem, the appropriate clinical team should be notified so the provider can determine whether another clinical decision is necessary.
Monitor Whether the Prescription Assistance Workflow Is Working
Measure the Workflow Without Overcomplicating It
Practices do not need to calculate the exact dollar amount saved through every assistance interaction to determine whether the workflow is useful.
For monitoring operational performance, more practical measures may include how many medication-access issues are identified and how many involve authorization versus financial assistance. They may also include how long assistance tasks remain unresolved and which medications or payer requirements repeatedly create problems.
Those patterns can reveal opportunities beyond individual assistance applications.
If one medication repeatedly creates affordability problems, providers may benefit from knowing that during prescribing decisions. If a particular payer consistently requires authorization for a drug class, the practice may be able to improve the authorization workflow.
If applications routinely stall because provider signatures are missing, that is an internal process problem rather than an assistance-program problem.
Operational Snapshot
Repeated access problems should become feedback for workflow design, not remain isolated patient cases. Trending barriers by medication, payer requirement, aging task, or stalled workflow step can show leadership where a prescribing pattern, authorization process, or internal handoff deserves intervention.
Medication affordability data can therefore inform both clinical and administrative operations. Leadership does not need an elaborate dashboard, but it should be able to recognize recurring barriers, long-open tasks, and workflow breakdowns that prevent patients from moving from prescription to access.
Close the Loop on Medication-Access Problems
Helping patients afford prescriptions is valuable, but a medical practice should not build the process around memorizing discount programs or searching the internet every time someone reports a high pharmacy price.
The more sustainable approach is a defined prescription assistance workflow.
Identify the barrier. Determine whether the issue is coverage, authorization, cost sharing, or affordability. Route the task to the appropriate staff member. Use current, reliable resources. Keep clinical decisions with qualified clinical staff. Document outstanding work. Follow the issue until there is a clear resolution, appropriate handoff, or next clinical decision.
That structure allows the practice to help patients without turning every affordability problem into an improvised administrative project.
Medication access sits at the intersection of clinical care, insurance administration, pharmacy benefits, and patient finances. When practices manage that intersection deliberately, they are better positioned to recognize when a prescribed treatment is not translating into an accessible treatment. They are also better positioned to respond before the problem becomes a gap in care.
Frequently Asked Questions About Prescription Assistance
What should a medical practice do when a patient says a prescription is too expensive?
First determine what is causing the cost problem. The medication may be non-formulary, require prior authorization or step therapy, have high patient cost sharing, or create a broader affordability problem. Identifying the barrier helps staff route the issue to the correct coverage, clinical, or prescription assistance workflow.
Who should handle prescription assistance in a medical practice?
The practice should define responsibility based on its staffing model. Clinical staff may identify the barrier, while designated administrative staff research assistance resources or track applications. Providers should remain responsible for clinical decisions. The important control is clear ownership so unresolved medication-access tasks do not disappear between roles.
Can Medicare patients use manufacturer prescription coupons?
Manufacturer savings programs establish their own eligibility requirements, and many copayment coupons exclude prescriptions paid for by Medicare, Medicaid, or other federal healthcare programs. Staff should review the current terms of the specific program rather than assuming a patient qualifies. Other assistance programs may have different eligibility rules.
Should staff recommend paying cash when it is cheaper than using insurance?
Staff can help patients understand available options, but they should avoid making the financial decision for them. A cash or discount-card transaction may be treated differently from a prescription processed through insurance and may affect how costs are credited under the patient’s benefit. Patients should confirm the coverage implications before deciding.
When is a prescription assistance task complete?
Submitting an application alone should not automatically close the task. The practice should have a defined endpoint, such as completion of its required assistance, confirmation of the next appropriate step, a documented handoff, or escalation back to the clinical team when the access problem remains unresolved and may affect treatment.
About the Author
Jennifer Blevens-Smith is the founder and principal consultant of Integral Clinic Solutions. With more than two decades of experience supporting independent medical practices, she helps physicians, practice administrators, and healthcare leaders strengthen credentialing, payer contracting, and revenue cycle operations. She also helps them strengthen compliance workflows and practice management. Her work focuses on translating complex healthcare requirements into practical operational processes. These processes improve consistency, reduce administrative burden, and support long-term practice success.
Need Help Strengthening Your Medical Practice Operations?
Integral Clinic Solutions provides practical support for medical practices navigating credentialing, contracting, revenue cycle operations, compliance workflows, front-office systems, and practice management challenges.
Explore more operational guidance, compliance insights, and healthcare business resources on the Integral Clinic Solutions blog. New articles and updates are added regularly for practice owners, administrators, and healthcare teams.
Disclaimer: This content is for informational and educational purposes only and does not constitute legal, coding, billing, compliance, financial, or medical advice. Healthcare practices must verify all operational requirements with applicable payers, regulators, and qualified professionals. Read our full Legal & Compliance Disclaimer.